Targeted delivery of chemically modified anti-miR-221 to hepatocellular carcinoma with negatively charged liposomes

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death. Gene therapy was established as a new strategy for treating HCC. To explore the potential delivery system to support the gene therapy of HCC, negatively charged liposomal delivery system was used to deliver miR-221...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wendian, Peng, Fangqi, Zhou, Taotao, Huang, Yifei, Zhang, Li, Ye, Peng, Lu, Miao, Yang, Guang, Gai, Yongkang, Yang, Tan, Ma, Xiang, Xiang, Guangya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524461/
https://www.ncbi.nlm.nih.gov/pubmed/26251599
http://dx.doi.org/10.2147/IJN.S79598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524461/
https://www.ncbi.nlm.nih.gov/pubmed/26251599
http://dx.doi.org/10.2147/IJN.S79598

Ejemplares similares